Decellularization is a biotechnological process that involves the removal of cellular components from tissues or organs, leaving behind a scaffold composed primarily of extracellular matrix (ECM). This technique aims to create acellular matrices that can serve as a foundation for tissue engineering and regenerative medicine applications. The process typically involves perfusing tissues or organs with a combination of detergents, enzymes, or other agents to break down and remove cells while preserving the structural integrity and biochemical composition of the ECM. Decellularized scaffolds provide a natural three-dimensional framework that retains essential ECM proteins, such as collagen and elastin, as well as signaling molecules crucial for tissue development and repair. These acellular matrices can be repopulated with specific cell types, promoting cell attachment, proliferation, and differentiation to regenerate functional tissues. Decellularization has been applied to various tissues, including heart, liver, kidney, and blood vessels, offering potential solutions for organ transplantation and tissue repair. The success of decellularization depends on achieving thorough cell removal while minimizing damage to the ECM. Researchers continue to refine decellularization techniques and explore novel applications, ranging from creating bioartificial organs to enhancing the repair of damaged tissues. Despite the promise of decellularization, challenges remain, such as immune response considerations and achieving complete cell removal. Ongoing advancements in this field hold significant potential for revolutionizing regenerative medicine and addressing the critical need for organ and tissue replacement therapies. In summary, decellularization is a transformative technique with applications in tissue engineering, creating acellular matrices that can serve as a platform for regenerative medicine and organ transplantation.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy